Trial Profile
Study of convernsion therapy using SOX chemotherapy plus Apatinib in local advanced or metastatic gastric cancer
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2017
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Gimeracil/oteracil/tegafur; Oxaliplatin
- Indications Adenocarcinoma; Gastric cancer
- Focus Therapeutic Use
- 06 Sep 2017 New trial record